All data are based on the daily closing price as of May 16, 2025
l

L&C Bio

290650.KQ
16.05 USD
-0.28
-1.71%

Overview

Last close
16.05 usd
Market cap
364.08M usd
52 week high
23.82 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
7.0484
Price/Book Value
1.787
Enterprise Value
434.80M usd
EV/Revenue
8.4322
EV/EBITDA
4.1139

Key financials

Revenue TTM
51.56M usd
Gross Profit TTM
25.56M usd
EBITDA TTM
6.65M usd
Earnings per Share
N/A usd
Dividend
0.04 usd
Total assets
322.67M usd
Net debt
68.10M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top